欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0827/001
药品名称Cisplatin 1 mg/ml concentrate for solution for infusion
活性成分
    • cisplatin 1.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Fresenius Kabi Austria GmbH Hafnerstraße 36 8055 Graz Austria
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Cisplatin 1 mg/ml concentrate for solution for infusion
    • Belgium (BE)
      Cisplatin Fresenius Kabi
    • Luxembourg (LU)
    • France (FR)
    • Lithuania (LT)
      Cisplatin Kabi 1 mg/ml koncentratas infuziniam tirpalui
    • Hungary (HU)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
      Cisplatin 1mg/ml concentrate for solution for infusion
许可日期2014/03/28
最近更新日期2020/08/19
药物ATC编码
    • L01XA01 cisplatin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase